Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: implication of high affinity type H+/peptide transporter PEPT2 mediated transport system-Reference-Cited by-同舟云学术

Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: implication of high affinity type H+/peptide transporter PEPT2 mediated transport system

Published:1999-08 Issue:2 Volume:271 Page:117-120
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Fujita Takuya,Kishida Takeshi,Okada Naoki,Ganapathy Vadivel,Leibach Frederick H,Yamamoto Akira

Publisher

Elsevier BV

Subject

General Neuroscience

Reference19 articles.

1. Renal assimilation of oligopeptides: physiological mechanisms and metabolic importance;Adibi;Am. J. Physiol.,1997

2. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system;Berger;Anat. Embryol.,1999

3. Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter;Boll;Proc. Natl. Acad. Sci. USA,1996

4. Identification of a renal cell line that constitutive expresses the kidney-specific high-affinity H+-peptide transporter;Brandsch;FASEB J.,1995

5. Expression cloning of mammalian proton-coupled oligopeptide transporter;Fei;Nature,1994

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An assessment of the transport mechanism and intraneuronal stability of l-carnosine;Amino Acids;2021-10-25

2. The Neuropeptide Kyotorphin as a Possible Biomarker and Neuroprotective Agent in Alzheimer’s Disease;Journal of Biomedical and Clinical Research;2020-09-01

3. Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives;Frontiers in Pharmacology;2017-01-12

4. Correlation between membrane translocation and analgesic efficacy in kyotorphin derivatives;Biopolymers;2015-01

5. Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?;Current Pharmaceutical Design;2014-03-31